scholarly article | Q13442814 |
P50 | author | Shyam Kottilil | Q87755004 |
P2093 | author name string | Michael A Polis | |
Anita Kohli | |||
Emily K Funk | |||
Henry Masur | |||
Amy Nelson | |||
Bhavana Shivakumar | |||
Laura Heytens | |||
Michael Sneller | |||
Richard Kwan | |||
Ashton Shaffer | |||
P2860 | cites work | Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients | Q28274666 |
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial | Q28298301 | ||
Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques | Q28775900 | ||
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy | Q34445911 | ||
Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons | Q34565853 | ||
HIV/hepatitis C coinfection natural history and disease progression | Q35801431 | ||
Pharmacokinetic properties of nucleoside/nucleotide reverse transcriptase inhibitors | Q35866777 | ||
Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis | Q37265953 | ||
Antiretroviral medications: adverse effects on the kidney | Q37652306 | ||
HIV and viral hepatitis coinfections: advances and challenges | Q38002790 | ||
Severity and correlates of liver disease in hepatitis C virus-infected injection drug users | Q39600856 | ||
Tenofovir nephrotoxicity: 2011 update | Q42254390 | ||
Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection | Q42989510 | ||
Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group | Q43036483 | ||
Hepatitis C virus infection and coinfection with human immunodeficiency virus: challenges and advancements in management | Q43038823 | ||
Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy | Q43693273 | ||
Serum hypophosphatemia in tenofovir disoproxil fumarate recipients is multifactorial in origin, questioning the utility of its monitoring in clinical practice | Q45285932 | ||
HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations | Q45423073 | ||
HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. | Q45489050 | ||
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group | Q45747079 | ||
Absence of clinically relevant pharmacokinetic interaction between ribavirin and tenofovir in healthy subjects. | Q50576419 | ||
Ribavirin potentiates the efficacy and toxicity of 2',3'- dideoxyinosine in the murine acquired immunodeficiency syndrome model. | Q50588689 | ||
Tenofovir disoproxil fumarate | Q73401251 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunology | Q101929 |
infectious disease | Q18123741 | ||
virology | Q7215 | ||
ribavirin | Q421862 | ||
Hepatitis C virus | Q708693 | ||
P304 | page(s) | 1190-1194 | |
P577 | publication date | 2013-06-14 | |
P1433 | published in | AIDS Research and Human Retroviruses | Q4651880 |
P1476 | title | Short communication: Interferon/ribavirin treatment for HCV is associated with the development of hypophosphatemia in HIV/hepatitis C virus-coinfected patients | |
P478 | volume | 29 |
Q41984358 | HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV-HCV co-infected patients: a 3-years follow-up study |
Q33988140 | Inteleukin-23 promotes interferon-α responsiveness in hepatitis C virus/HIV-coinfected patients |
Q37062210 | Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin |
Search more.